Literature DB >> 27542636

Radiologic Approach to Bone and Soft Tissue Sarcomas.

Jamie T Caracciolo1, G Douglas Letson2.   

Abstract

Diagnostic imaging plays an important role in evaluation and treatment planning of patients with musculoskeletal tumors. This article discusses various imaging modalities available in the work-up, staging, and surveillance of patients with primary bone and soft tissue neoplasms. A systematic approach to initial evaluation of newly suspected bone lesions and soft tissue masses is presented. Reviewed are relevant imaging features of musculoskeletal neoplasms that help predict tumor biology and risk of malignancy and findings that define internal tumor composition and allow for accurate preoperative histopathologic diagnosis before intervention. Finally, the role of diagnostic imaging in tumor staging, evaluation of response to neoadjuvant therapy, and postoperative surveillance is discussed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone lesion; Diagnostic evaluation; Imaging; Radiology; Sarcoma; Soft tissue mass

Mesh:

Year:  2016        PMID: 27542636     DOI: 10.1016/j.suc.2016.05.007

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

Review 1.  CT and MRI of superficial solid tumors.

Authors:  Jingfeng Zhang; Yanyuan Li; Yilei Zhao; Jianjun Qiao
Journal:  Quant Imaging Med Surg       Date:  2018-03

Review 2.  [Postoperative and posttherapeutic changes after primary bone tumors : What's important for radiologists?]

Authors:  T Grieser; I-M Nöbauer-Huhmann
Journal:  Radiologe       Date:  2017-11       Impact factor: 0.635

Review 3.  Interventional Radiology in the Management of Metastases and Bone Tumors.

Authors:  Ferruccio Sgalambro; Luigi Zugaro; Federico Bruno; Pierpaolo Palumbo; Nicola Salducca; Carmine Zoccali; Antonio Barile; Carlo Masciocchi; Francesco Arrigoni
Journal:  J Clin Med       Date:  2022-06-07       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.